Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.18B | 2.02B | 1.90B | 1.79B | 1.68B | 1.50B |
Gross Profit | 723.16M | 635.54M | 595.43M | 553.23M | 542.40M | 454.51M |
EBITDA | 232.03M | 187.38M | 44.35M | -517.28M | -9.26M | 22.13M |
Net Income | 18.55M | -10.93M | -134.52M | -662.03M | -117.04M | -57.05M |
Balance Sheet | ||||||
Total Assets | 1.77B | 1.66B | 1.61B | 1.71B | 2.33B | 1.84B |
Cash, Cash Equivalents and Short-Term Investments | 100.74M | 84.29M | 43.94M | 19.22M | 30.49M | 137.34M |
Total Debt | 1.49B | 1.50B | 1.50B | 1.50B | 1.30B | 1.23B |
Total Liabilities | 1.78B | 1.79B | 1.74B | 1.72B | 1.70B | 1.58B |
Stockholders Equity | -11.99M | -122.09M | -127.44M | -4.17M | 637.95M | 267.17M |
Cash Flow | ||||||
Free Cash Flow | 78.52M | 26.32M | 16.56M | -60.41M | -27.30M | 101.38M |
Operating Cash Flow | 85.74M | 32.64M | 22.67M | -48.40M | -11.35M | 116.62M |
Investing Cash Flow | -22.07M | -6.32M | -8.79M | -25.29M | -681.83M | -193.54M |
Financing Cash Flow | -10.59M | 14.03M | 10.85M | 62.42M | 586.33M | 210.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $1.30B | 37.54 | 7.02% | 2.09% | 16.24% | 116.58% | |
71 Outperform | $832.25M | 31.06 | 11.44% | ― | 30.58% | 24.86% | |
68 Neutral | $1.14B | 111.87 | 2.28% | ― | 5.17% | -65.33% | |
59 Neutral | $1.69B | 109.31 | 42.49% | ― | 11.53% | ― | |
56 Neutral | $775.30M | 18.62 | -40.13% | ― | -14.33% | -398.68% | |
51 Neutral | $7.92B | -0.43 | -41.67% | 2.21% | 22.29% | -1.85% | |
46 Neutral | $1.82B | ― | -108.91% | ― | 3.99% | -14.74% |
On August 8, 2025, Aveanna Healthcare Holdings Inc. released a financial presentation to investors, highlighting key operating statistics and financial metrics. The presentation reported over $2.3 billion in revenue, a gross margin of 34.3%, and an adjusted EBITDA exceeding $270 million. The company operates 366 locations with 29,000 caregivers, delivering 43.9 million homecare hours annually. This announcement underscores Aveanna’s robust operational scale and financial performance, reinforcing its position as a major player in the home healthcare sector.
Aveanna Healthcare Holdings announced its second-quarter financial results for 2025, showing significant growth in revenue and adjusted EBITDA compared to the previous year. The company reported a 16.8% increase in revenue to $589.6 million and a 93.6% increase in adjusted EBITDA to $88.4 million. The acquisition of Thrive Skilled Pediatric Care has expanded Aveanna’s pediatric services, contributing to its strategic transformation and market expansion. The company has raised its full-year 2025 revenue guidance to over $2.3 billion and adjusted EBITDA to over $270 million, reflecting strong operational performance and growth momentum.
On June 25, 2025, Aveanna Healthcare Holdings Inc.’s subsidiaries, Aveanna Healthcare LLC and Aveanna SPV I, LLC, entered into a seventh amendment to their Receivables Financing Agreement with a bank. This amendment increased the facility limit to $275 million and extended the termination date by three years, impacting the company’s financial flexibility and operational strategy.